Polyrizon Ltd.(PLRZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PLRZ Polyrizon Ltd.

Market Closed 06-05 16:00:00 EDT

12.99

+0.19

+1.48%

盘后12.99

+0.000.00%

17:38 EDT

High13.60	Low11.01	Vol48.22K
Open12.67	D1 Closing12.80	Amplitude20.23%
Mkt Cap24.32M	Tradable Cap22.73M	Total Shares1.87M
T/O596.69K	T/O Rate2.76%	Tradable Shares1.75M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PLRZ","market":"US","secType":"STK","nameCN":"Polyrizon Ltd.","latestPrice":12.99,"timestamp":1780689600000,"preClose":12.8,"halted":0,"volume":48221,"hourTrading":{"tag":"盘后","latestPrice":12.99,"preClose":12.99,"latestTime":"17:38 EDT","volume":88,"amount":1102.77,"timestamp":1780695486099,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.014843749999999961,"floatShares":1749900,"shares":1871848,"eps":-0.71144193,"marketStatus":"Market Closed","change":0.19,"latestTime":"06-05 16:00:00 EDT","open":12.67,"high":13.6,"low":11.01,"amount":596692.826288,"amplitude":0.202344,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.71144193,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780905600000},"marketStatusCode":7,"adr":0,"listingDate":1730174400000,"exchange":"NASDAQ","adjPreClose":12.8,"preHourTrading":{"tag":"盘前","latestPrice":13.54,"preClose":12.8,"latestTime":"07:04 EDT","volume":1,"amount":13.54,"timestamp":1780657471341,"change":0.74,"changeRate":0.057812,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":12.99,"preClose":12.99,"latestTime":"17:38 EDT","volume":88,"amount":1102.77,"timestamp":1780695486099,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.8590297046338016},"requestUrl":"/m/hq/s/PLRZ/wiki","defaultTab":"wiki","newsList":[{"id":"2641914704","title":"Polyrizon: Co & Arrow Aviation Entered Into Letter Agreement Extending Exclusivity Period & Initial Negotiation Period Under Mou to June 30","url":"https://stock-news.laohu8.com/highlight/detail?id=2641914704","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641914704?lang=en_us&edition=fundamental","pubTime":"2026-06-06 04:24","pubTimestamp":1780691049,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nFWN42D0IJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638636309","title":"Polyrizon appoints Ami Oren as Class I director","url":"https://stock-news.laohu8.com/highlight/detail?id=2638636309","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638636309?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:26","pubTimestamp":1779913603,"startTime":"0","endTime":"0","summary":"Polyrizon appointed Ami Oren as a Class I director, effective May 14, 2026.Oren, 51, founded and ran Hummus Ami from 2015 to 2026, overseeing finance, procurement, staffing, customer experience.He exited the business through a sale; earlier operated an independent catering and culinary operation for large-scale events.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polyrizon Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL3bLwkk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635975780","title":"Polyrizon signs first U.S. clinical trial agreement for NASARIX allergy blocker study","url":"https://stock-news.laohu8.com/highlight/detail?id=2635975780","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635975780?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:25","pubTimestamp":1778678740,"startTime":"0","endTime":"0","summary":"Polyrizon signed first U.S. clinical trial agreement with an allergy-focused clinical research site in Texas to start human testing of NASARIX  seasonal allergic rhinitis nasal spray.Texas site set to serve as first center in planned multi-center study comparing PL-14 efficacy, safety, tolerability versus saline spray.Agreement marks initial U.S. site activation step ahead of planned first-in-human clinical program; additional sites expected in coming months.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL1lwgMf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2210150020.SGD","SG9999014021.USD","BK4588","SG9999014013.SGD","IE00BKPKM429.USD","BK4139","SG9999014039.USD","BK4112","PLRZ","LU2210149790.SGD","IE00BN0W2T93.GBP","SG9999014005.SGD","IE00BN0W2W23.USD","NDAQ","BK4585","LU0314104364.USD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635780617","title":"Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for Nasarix™ Allergy Blocker Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2635780617","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635780617?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:25","pubTimestamp":1778678700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nTUA68YTHG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632955811","title":"Polyrizon expands U.S. patent claims for intranasal drug delivery platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2632955811","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632955811?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:54","pubTimestamp":1777899256,"startTime":"0","endTime":"0","summary":"Polyrizon submitted amended claims in a U.S. patent application to broaden protection for its intranasal drug-delivery hydrogel platform beyond core mucoadhesive composition to cover drug-delivery systems and methods of use.Claims target formulations using sulfated polysaccharide polymers with additional polymer components designed to form a continuous film on contact with nasal mucosa, aiming to increase drug residence time and improve bioavailability.Move supports strategy to strengthen intellectual property position for intranasal delivery across local and systemic drug administration.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polyrizon Ltd. published the original content used to generate this news brief via EDGAR, the Electron","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL11KcPG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630585230","title":"Polyrizon Ltd trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2630585230","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630585230?lang=en_us&edition=fundamental","pubTime":"2026-04-28 22:31","pubTimestamp":1777386663,"startTime":"0","endTime":"0","summary":"09:58 EDT Polyrizon (PLRZ) Ltd trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-movin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polyrizon-ltd-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polyrizon-ltd-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630058825","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:58 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2630058825","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630058825?lang=en_us&edition=fundamental","pubTime":"2026-04-28 21:58","pubTimestamp":1777384732,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:58 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nAQN2LWI02:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630397423","title":"Polyrizon files European patent application for Trap & Target platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2630397423","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630397423?lang=en_us&edition=fundamental","pubTime":"2026-04-27 21:57","pubTimestamp":1777298252,"startTime":"0","endTime":"0","summary":"Polyrizon (PLRZ) announced the filing of a divisional patent application with the Europe Patent Office for its Trap & Target platform technology. T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polyrizon-files-european-patent-application-for-trap-target-platform-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polyrizon-files-european-patent-application-for-trap-target-platform-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1267930490.SGD","LU2237443549.SGD","BK4504","LU0128525689.USD","LU1267930227.SGD","BK4596","LU2237443978.SGD","LU1244550494.USD","LU0052756011.USD","LU0211328371.USD","LU2237443382.USD","LU2237443622.USD","BK4532","LU1244550577.SGD","BK4597","TGT","BK4585","LU1244550221.USD","BK4588","BK4533","PLRZ","BK4114","LU0310800965.SGD","LU0823411888.USD","BK4155","LU0211327993.USD","BK4139","LU0310799852.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630392431","title":"Polyrizon: Announces Filing of European Patent Application for Its Drug Delivery Platform - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2630392431","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630392431?lang=en_us&edition=fundamental","pubTime":"2026-04-27 21:33","pubTimestamp":1777296806,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nFWN41A0DQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629286426","title":"Polyrizon files to sell 0.5M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2629286426","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629286426?lang=en_us&edition=fundamental","pubTime":"2026-04-24 07:30","pubTimestamp":1776987028,"startTime":"0","endTime":"0","summary":"19:28 EDT Polyrizon (PLRZ) files to sell 0.5M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, mar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polyrizon-files-to-sell-0-5m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polyrizon-files-to-sell-0-5m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626892299","title":"Polyrizon closes unregistered private placement, raises $3.5 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2626892299","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626892299?lang=en_us&edition=fundamental","pubTime":"2026-04-09 04:20","pubTimestamp":1775679608,"startTime":"0","endTime":"0","summary":"Polyrizon closed a $3.5 million registered direct offering with a concurrent unregistered private placement with a single institutional investor.Private placement issued 111,111 pre-funded warrants with 388,888 common warrants at a $9 unit price.Net proceeds earmarked for general corporate purposes, working capital.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDL2WzwpS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","SG9999014021.USD","SG9999014039.USD","LU0314104364.USD","BK4112","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4585","NDAQ","BK4139","IE00BGHQF748.EUR","LU2095319765.USD","PLRZ","IE00BKPKM429.USD","BK4588","LU2210149790.SGD","IE00BN0W2W23.USD","SG9999014013.SGD","LU2210150020.SGD","SG9999014005.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625559509","title":"Polyrizon sells unregistered warrants in $3.5 million private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2625559509","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625559509?lang=en_us&edition=fundamental","pubTime":"2026-04-07 21:21","pubTimestamp":1775568115,"startTime":"0","endTime":"0","summary":"Polyrizon priced a concurrent private placement with a single institutional investor alongside a registered direct offering, targeting aggregate gross proceeds of about USD 3.5 million.Private placement includes 111,111 pre-funded warrants, each exercisable for 1 ordinary share.Investor also receives 388,888 common warrants with an exercise price of USD 9 per share.Post-transaction share count is expected to be 2,083,939 ordinary shares outstanding assuming exercise of all pre-funded warrants.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polyrizon Ltd. published the original content used to generate this news brief on April 07, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL2ds3W7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625930913","title":"BRIEF-Polyrizon Ltd - Enters Agreements For Registered Direct Offering Of Ordinary Shares And Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2625930913","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625930913?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:05","pubTimestamp":1775563521,"startTime":"0","endTime":"0","summary":"BRIEF-Polyrizon Ltd - Enters Agreements For Registered Direct Offering Of Ordinary Shares And Pre-Funded WarrantsApril 7 (Reuters) - Polyrizon Ltd PLRZ.O:POLYRIZON LTD - ENTERS AGREEMENTS FOR REGISTER","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nFWN40Q01Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625930371","title":"Polyrizon Ltd - Expects Aggregate Gross Proceeds of $3.5 Mln From Offering and Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2625930371","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625930371?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:00","pubTimestamp":1775563220,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nFWN40Q01Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625303459","title":"Polyrizon Ltd - Enters Agreements for Registered Direct Offering of Ordinary Shares and Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2625303459","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625303459?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:00","pubTimestamp":1775563220,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nFWN40Q01Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625587049","title":"Polyrizon Ltd. Announces $3.5 Million Registered Direct Offering and Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2625587049","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625587049?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:00","pubTimestamp":1775563200,"startTime":"0","endTime":"0","summary":"RAANANA, ISRAEL, April  07, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/07/3269086/0/en/Polyrizon-Ltd-Announces-3-5-Million-Registered-Direct-Offering-and-Private-Placement.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624492265","title":"Polyrizon Director Oz Adler disposes of USD 0.0 million common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2624492265","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624492265?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:16","pubTimestamp":1775074572,"startTime":"0","endTime":"0","summary":"Polyrizon director Oz Adler sold 3,292 ordinary shares on March 31, 2026.Direct holdings fell to 19,850 ordinary shares following transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polyrizon Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL2fqVnf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Polyrizon Director Oz Adler disposes of USD 0.0 million common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624530526","title":"Polyrizon director Carmel Liron disposes of shares worth $0.0011 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624530526","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624530526?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:25","pubTimestamp":1774988712,"startTime":"0","endTime":"0","summary":"Polyrizon director Carmel Liron sold 100 ordinary shares on March 30, 2026.Holdings fell to 4,069 ordinary shares following transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polyrizon Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL8FLtNz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624530534","title":"Polyrizon CEO Tomer Izraeli disposes of 3,900 shares worth $0.04 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624530534","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624530534?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:24","pubTimestamp":1774988647,"startTime":"0","endTime":"0","summary":"Polyrizon CEO Tomer Izraeli sold 3,900 ordinary shares on March 30, 2026 at USD 10.9 per share.Izraeli reported beneficial ownership of 32,012 ordinary shares following transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polyrizon Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL39DCCT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Polyrizon CEO Tomer Izraeli disposes of 3,900 shares worth $0.04 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622543863","title":"Polyrizon completes FDA pre-submission meeting for NASARIX; submits FDA Pre-RFD for PL-16 viral blocker","url":"https://stock-news.laohu8.com/highlight/detail?id=2622543863","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622543863?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:23","pubTimestamp":1774531400,"startTime":"0","endTime":"0","summary":"Polyrizon completed an FDA pre-submission meeting for its PL-14  allergy blocker to discuss clinical development strategy and potential human trials.The company submitted a pre-request for designation to the FDA for its PL-16 viral blocker.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL6ZtQKY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","BK4139","SG9999014005.SGD","NDAQ","IE00BKPKM429.USD","PLRZ","LU2210149790.SGD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4588","BK4585","SG9999014013.SGD","BK4112","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","SG9999014021.USD","LU2210150020.SGD","LU2095319765.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.polyrizon-biotech.com","stockEarnings":[{"period":"1week","weight":-0.2434},{"period":"1month","weight":-0.0938},{"period":"3month","weight":-0.0092},{"period":"6month","weight":-0.0084},{"period":"1year","weight":1.5579},{"period":"ytd","weight":0.53}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":0.0051},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.0756},{"period":"1year","weight":0.2437},{"period":"ytd","weight":0.0816}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Polyrizon Ltd.","nameEN":"Polyrizon Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Polyrizon Ltd.(PLRZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Polyrizon Ltd.(PLRZ) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Polyrizon Ltd.,PLRZ,Polyrizon Ltd.股票,Polyrizon Ltd.股票老虎,Polyrizon Ltd.股票老虎国际,Polyrizon Ltd.行情,Polyrizon Ltd.股票行情,Polyrizon Ltd.股价,Polyrizon Ltd.股市,Polyrizon Ltd.股票价格,Polyrizon Ltd.股票交易,Polyrizon Ltd.股票购买,Polyrizon Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Polyrizon Ltd.(PLRZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Polyrizon Ltd.(PLRZ) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}